Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 623

1.

Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.

Satta N, Pagano S, Montecucco F, Gencer B; Swiss HIV Cohort Study, Mach F, Kaiser L, Calmy A, Vuilleumier N.

J Infect. 2018 Feb;76(2):186-195. doi: 10.1016/j.jinf.2017.11.008. Epub 2017 Dec 14.

PMID:
29198606
2.

L’éthique tue-t-elle l’enthousiasme de la recherche ?

Hirschel B.

Rev Med Suisse. 2016 Dec 7;12(542):2137. French. No abstract available.

PMID:
28700169
3.

Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa?

Abbas M, Emonet S, Köhler T, Renzi G, van Delden C, Schrenzel J, Hirschel B.

Front Microbiol. 2017 May 30;8:953. doi: 10.3389/fmicb.2017.00953. eCollection 2017.

4.

Infection-related and -unrelated malignancies, HIV and the aging population.

Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.

HIV Med. 2016 Sep;17(8):590-600. doi: 10.1111/hiv.12359. Epub 2016 Feb 18.

5.

The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events.

Wandeler G, Kraus D, Fehr J, Conen A, Calmy A, Orasch C, Battegay M, Schmid P, Bernasconi E, Furrer H; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):302-9. doi: 10.1097/QAI.0000000000000864.

6.

Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period.

Aebi-Popp K, Kouyos R, Bertisch B, Staehelin C, Rudin C, Hoesli I, Stoeckle M, Bernasconi E, Cavassini M, Grawe C, Lecompte TD, Rickenbach M, Thorne C, Martinez de Tejada B, Fehr J; Swiss Mother and Child HIV Cohort Study; Swiss HIV Cohort Study.

HIV Med. 2016 Apr;17(4):280-8. doi: 10.1111/hiv.12299. Epub 2015 Aug 12.

7.

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.

Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D Study Group.

HIV Med. 2016 Apr;17(4):255-68. doi: 10.1111/hiv.12294. Epub 2015 Jul 28.

8.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD.

N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.

9.

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.

Bihl F, Martinetti G, Wandeler G, Weber R, Ledergeber B, Calmy A, Battegay M, Cavassini M, Vernazza P, Caminada AP, Rickenbach M, Bernasconi E; Swiss HIV Cohort Study.

BMC Gastroenterol. 2015 Jul 8;15:79. doi: 10.1186/s12876-015-0308-0.

10.

Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.

Ciaffi L, Cavassini M, Genne D, Delhumeau C, Spycher Elbes R, Hill A, Wandeler G, Fehr J, Stoeckle M, Schmid P, Hirschel B, Montecucco F, Calmy A; Swiss HIV Cohort Study.

Eur J Clin Invest. 2015 Jul;45(7):720-30. doi: 10.1111/eci.12464.

11.

Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.

Podlekareva D, Grint D, Karpov I, Rakmanova A, Mansinho K, Chentsova N, Zeltina I, Losso M, Parczewski M, Lundgren JD, Mocroft A, Kirk O; EuroSIDA in EuroCoord.

HIV Med. 2015 Oct;16(9):533-43. doi: 10.1111/hiv.12254. Epub 2015 May 18.

12.

Treatment of Clostridium difficile infection in a French university hospital.

Khanafer N, Blais L, Barbut F, Hirschel B, Vanhems P.

Scand J Gastroenterol. 2015;50(10):1253-60. doi: 10.3109/00365521.2015.1033746. Epub 2015 Apr 15.

PMID:
25877477
13.

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

Boesecke C, Grint D, Soriano V, Lundgren JD, d'Arminio Monforte A, Mitsura VM, Chentsova N, Hadziosmanovic V, Kirk O, Mocroft A, Peters L, Rockstroh JK; EuroSIDA in EuroCoord.

Liver Int. 2015 Nov;35(11):2384-91. doi: 10.1111/liv.12848. Epub 2015 Apr 29.

PMID:
25875966
14.

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.

15.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
16.

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD.

HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available.

17.

Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.

Carballo D, Delhumeau C, Carballo S, Bähler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A; Swiss HIV Cohort Study and AMIS registry.

AIDS Res Ther. 2015 Feb 22;12:4. doi: 10.1186/s12981-015-0045-z. eCollection 2015.

18.

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.

Borges ÁH, Lundgren JD, Ridolfo A, Katlama C, Antunes F, Grzeszczuk A, Blaxhult A, Mitsura VM, Doroana M, Battegay M, Gargalianos P, Mocroft A; EuroSIDA in EuroCOORD.

AIDS. 2014 Nov 13;28(17):2565-71. doi: 10.1097/QAD.0000000000000433.

PMID:
25574959
19.

Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study.

Rosin C, Elzi L, Thurnheer C, Fehr J, Cavassini M, Calmy A, Schmid P, Bernasconi E, Battegay M; Swiss HIV Cohort Study.

HIV Med. 2015 May;16(5):319-25. doi: 10.1111/hiv.12203. Epub 2014 Oct 20.

20.

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients.

Bibert S, Wojtowicz A, Taffé P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, Cavassini M, Bochud PY; Swiss HIV Cohort Study.

AIDS. 2014 Aug 24;28(13):1885-9. doi: 10.1097/QAD.0000000000000379.

Supplemental Content

Loading ...
Support Center